EMALEX BIOSCIENCES Trademark

Trademark Overview


On Thursday, February 22, 2024, a trademark application was filed for EMALEX BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the EMALEX BIOSCIENCES trademark a serial number of 98417011. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 15, 2024. This trademark is owned by Emalex Biosciences, Inc.. The EMALEX BIOSCIENCES trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceuticals and pharmaceutical preparations, namely, for the treatment of Tourette Syndrome and other central nervous system disorders

Providing healthcare and medical information; healthcare services, namely providing information in the field of health, wellness, Tourette Syndrome and other central nervous system disorders; providing website featuring information in the field of central nervous system disorders treatments; providing information, news, and commentary in the field of central nervous system disorders

Research and development of medications and treatment for central nervous system disorders
emalex biosciences

General Information


Serial Number98417011
Word MarkEMALEX BIOSCIENCES
Filing DateThursday, February 22, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2024

Trademark Statements


Goods and ServicesPharmaceuticals and pharmaceutical preparations, namely, for the treatment of Tourette Syndrome and other central nervous system disorders
Goods and ServicesProviding healthcare and medical information; healthcare services, namely providing information in the field of health, wellness, Tourette Syndrome and other central nervous system disorders; providing website featuring information in the field of central nervous system disorders treatments; providing information, news, and commentary in the field of central nervous system disorders
NOT AVAILABLEBIOSCIENCES
Goods and ServicesResearch and development of medications and treatment for central nervous system disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 22, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 22, 2024
Primary Code042
First Use Anywhere DateWednesday, August 1, 2018
First Use In Commerce DateWednesday, August 1, 2018

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 22, 2024
Primary Code044
First Use Anywhere DateWednesday, August 1, 2018
First Use In Commerce DateWednesday, August 1, 2018

Trademark Owner History


Party NameEmalex Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChicago, IL 60611

Party NameEmalex Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChicago, IL 60611

Trademark Events


Event DateEvent Description
Thursday, February 22, 2024NEW APPLICATION ENTERED
Saturday, June 29, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 27, 2024ASSIGNED TO EXAMINER
Wednesday, August 28, 2024NON-FINAL ACTION E-MAILED
Wednesday, August 28, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 10, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 10, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 10, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 10, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 25, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 15, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 15, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, August 28, 2024NON-FINAL ACTION WRITTEN